ClinicalTrials.Veeva

Menu

SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia

Scripps Health logo

Scripps Health

Status

Completed

Conditions

Cervical Cancer

Treatments

Device: Mobile OCT M3 scope

Study type

Interventional

Funder types

Other

Identifiers

NCT02272075
Scripps-Mobile OCT 1

Details and patient eligibility

About

This trial will compare images obtained from a mobile colposcope with those obtained using a standard of care.

Full description

This trial will compare images obtained from a mobile colposcope with those obtained using a standard colposcope in women with abnormal pap smears. It is a non-inferiority trial. Blinded images will be evaluated be experts in colpsocopy and compared

Enrollment

30 patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: abnormal cervical cancer screening by pap smear of high risk HPV test -

Exclusion Criteria: no consent

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 2 patient groups

active colposcope
Active Comparator group
Description:
Mobile OCT M3 scope
Treatment:
Device: Mobile OCT M3 scope
Standard of Care
No Intervention group
Description:
Standard of Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems